We carried out chromosomal analysis of a 33-year-old male who was diagnosed as having aplastic anemia. The patient showed severe pancytopenia, a normal NAP score, hypoplastic marrow and no myelodysplastic changes. 45,XO was found in all bone marrow cells examined, and in 10% of peripheral blood cells examined. To our knowledge, this is the first reported case of male aplastic anemia to show loss of the Y chromosome in all bone marrow cells examined, and this case may suggest a possible mechanism of juvenile onset of aplastic anemia. (Internal Medicine 31: 273-276, 1992) 
Intr oduction
Aneuploidy is frequently used as an indication of clonality in hematological neoplasms, but loss of the Y chromosome as a clonal marker has been a subject of debate, since it has occasionally been found in "normal" males (1-4). Here we report a case of aplastic anemia in a male who showed loss of the Y chromosome in all bone marrow cells examined, and discuss a possible mechanism of juvenile onset of aplastic anemia. Case Report
The patient was first found to be anemic in 1967 when he was 10yr of age, and he was diagnosed as having aplastic anemia in 1971. Although he had been treated with corticosteroid and anabolic steroid, pancytopenia slowly progressed. Later, exertional dyspnea and leg edema worsened, and he was admitted to our hospital in June 1990. On admission, the palpebral conjunctiva was severely anemic, there were several areas of purpura and petechiae on the arms, and the legs were moderately edematous. The patient did not show any sign of skin pigmentation, hypoplasia of kidney or spleen, absent or hypoplastic thumb or radius, microcephaly, or mental or sexual retardation. The patient had no family history of anemia. The laboratory data are summarized in Table 1 .
The peripheral blood showed marked pancytopenia. Bone marrow aspiration revealed hypocellular tissue fragments without signs of myelodysplasia, such as with 45,XO cells (3). In their study also, almost all of the individuals with 45,XO were above the age of 60yr, and none of the 75 individuals below 50yr of age had the loss of the Y chromosome. These researchers concluded that loss of the Y chromosome in marrow cells is a rather common event in aging males, and is not related to any specific hematological disease.
On the other hand, Rowley examined bone marrow cells of 100 males and found only 3 Y-minus individuals (4). These 3 males all had thrombocytopenia, and none of 43 control individuals without hematological disorders had 45,XO cells. Similar results were also reported by Nava (7) and Jensen (8) . Rowley (4) concluded that the Y-minus condition is found more frequently in males with hematological disorders, and that the use of males with carcinomas as "controls" in other studies might introduce serious bias. cases of aplastic anemia showed chromosomal abnor mality, and that no case showed a loss of the Y chromo some (9). Sakurai formerly reported 2 patients with aplastic anemia, 13 and 61yr of age, who had 45,XO (5). However, these patients were different from the present patient in that the frequency of 45,XO cells in bone marrow was less than 50%. These patients showed no 45,XO cells in the peripheral blood. It is interesting for a 13-year-old patient with aplastic anemia to show 45,XO cells. The present patient also developed aplastic anemia when he was ajuvenile (10yr of age). Since there have been almost no reports of normal individuals under the age of 40yr having 45,XO cells, it may be suggested that loss of the Y chromosome is related to the onset of juvenile aplastic anemia. One recent finding of interest is that the gene for the granulocyte-macrophage colony stimulating factor receptor (GM-CSFR) was found to be located on the sex chromosomes (10 blood cells showed 45,XO. Interestingly, in the "normal" individuals with loss of the Y chromosome, the frequency of 45,XO cells is also reported to be much lower in the peripheral blood than in bone marrow (2, 3) . The reason for this finding was thought to be the fact that the major dividing cells in peripheral blood are lymphocytes, whereas in bone marrow, they are myeloid cells (2, 12) . In the present patient, this assumption seems feasible because the frequency of 45,XO cells in bone marrow was only 20% on stimulation with PHA, a stimulant of lymphocyte growth. In summary, a male patient with aplastic anemia showing loss of the Y chromosome is reported. This patient is of interest in that all bone marrow cells exam ined showed 45,XO, suggesting a possible mechanism of onset of juvenile aplastic anemia.
